18F-PSMA PET/CT tracer

18F-PSMA · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 18F-PSMA PET/CT tracer, covering 2025-01-09 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. [Phase 2]

See pricing